MedPath
HSA Approval

VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG

SIN15070P

VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG

VANCOMYCIN KABI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG

August 22, 2016

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

J01XA01

vancomycin

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Xellia Pharmaceuticals ApS

Active Ingredients

Vancomycin hydrochloride 512mg eqv Vancomycin

500mg/vial

Vancomycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.